The CEO highlighted results from the REMAIN-1 Midpoint Cohort, where "Revita-treated patients lost an additional 2.5% of total body weight, while patients in the sham group regained about 10%, a ...
Currently, no FDA-approved drug therapies exist for pediatric patients with abdominal pain-related disorders of gut-brain interaction (DGBIs), a significant unmet medical need. In the absence of ...
Detailed price information for Sensus Healthcare Inc (SRTS-Q) from The Globe and Mail including charting and trades.
Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBrian Luque - Head of Investor Relations & ...
Q3 2025 Earnings Call Transcript November 11, 2025 Operator: Good day, and welcome to the Spectral AI Inc. Q3 2025 Financial Results Conference Call. [Operator Instructions] Please note, this event is ...
On Tuesday, the Texas A&M Rural and Community Health Institute started training for healthcare providers in rural areas. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback